✦ LIBER ✦

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment

✍ Scribed by Macha, S.; Mattheus, M.; Halabi, A.; Pinnetti, S.; Woerle, H. J.; Broedl, U. C.

Book ID: 124056586
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 598 KB
Volume: 16
Category: Article
ISSN: 1462-8902
DOI: 10.1111/dom.12182

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Empagliflozin, a Sod

Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor, Coadministered with Sitagliptin in Healthy Volunteers

✍ Tobias Brand, Sreeraj Macha, Michaela Mattheus, Sabine Pinnetti, Hans J. Woerle 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 1015 KB

Empagliflozin, a novel selective sodium

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors

✍ R. Grempler; L. Thomas; M. Eckhardt; F. Himmelsbach; A. Sauer; D. E. Sharp; R. A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Efficacy and safety of empagliflozin, a

Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia

✍ Rosenstock, J.; Seman, L. J.; Jelaska, A.; Hantel, S.; Pinnetti, S.; Hach, T.; W 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Sergliflozin, a Novel Selective Inhibito

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

✍ Katsuno, K.; Fujimori, Y.; Takemura, Y.; Hiratochi, M.; Itoh, F.; Komatsu, Y.; F 📂 Article 📅 2006 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 413 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

✍ Elizabeth K Hussey, Anita Kapur, Robin O’Connor-Semmes… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 291 KB